Evidence to Recommendations for rVSVΔG-ZEBOV-GP Ebola Vaccine (cdc.gov)
0xBASE INTEL BRIEF
- CDC assessment of rVSV-ZEBOV supports vaccine policy and deployment
- Review covers efficacy, safety, and immunogenicity data
- Informs ring vaccination and preventive campaign strategies
"The CDC conducted an evidence review for the rVSV-ZEBOV Ebola vaccine, assessing efficacy, safety, and deployment strategies. The findings inform vaccine deployment decisions and operational planning for outbreak response, supporting policy and humanitarian efforts."
no comments yet.